PSP
RDY icon

Principal Street Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Principal Street Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,616
Closed -$162K – 272
2025
Q3 		$162K Sell
11,616
-3,696
-24% -$53.2K 0.03% 262
2025
Q2 		$230K Buy
+15,312
New +$219K 0.02% 324

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Principal Street Partners's RDY Position: Q4 2025 in Review

Principal Street Partners sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 11,616 shares — an estimated $162K sold.

Principal Street Partners first reported a position in RDY in Q2 2025 and held it in 2 quarters. The position peaked at $230K in Q2 2025. 235 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • Principal Street Partners reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • Principal Street Partners sold 11,616 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $162K.
  • Principal Street Partners first reported a position in Dr. Reddy's Laboratories in Q2 2025 and held it in 2 quarters.
  • Principal Street Partners's Dr. Reddy's Laboratories position peaked at $230K in Q2 2025.
  • 235 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Principal Street Partners's 13F filing for Q4 2025, filed 17 Feb 2026.